Comparison	O
of	O
constitutive	O
and	O
inducible	O
transcriptional	O
enhancement	O
mediated	O
by	O
kappa	B-DNA
B-related	I-DNA
sequences	I-DNA
:	O
modulation	O
of	O
activity	O
in	O
B	B-cell_type
cells	I-cell_type
by	O
human	B-DNA
T-cell	I-DNA
leukemia	I-DNA
virus	I-DNA
type	I-DNA
I	I-DNA
tax	I-DNA
gene	I-DNA
.	O

The	O
kappa	B-DNA
B	I-DNA
sequence	I-DNA
(	O
GGGACTTTCC	O
)	O
binds	O
a	O
factor	O
,	O
NF-kappa	B-protein
B	I-protein
,	O
that	O
is	O
constitutively	O
found	O
in	O
its	O
functional	O
,	O
DNA	O
binding	O
form	O
only	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

A	O
factor	O
with	O
apparently	O
indistinguishable	O
sequence	O
specificity	O
can	O
be	O
induced	O
in	O
many	O
other	O
cell	O
types	O
,	O
where	O
it	O
is	O
used	O
to	O
regulate	O
inducible	O
gene	O
expression	O
.	O

For	O
example	O
,	O
kappa	B-DNA
B-related	I-DNA
sequences	I-DNA
have	O
been	O
shown	O
to	O
be	O
important	O
for	O
the	O
transcription	O
of	O
a	O
few	O
inducible	O
genes	O
,	O
such	O
as	O
the	O
interleukin	B-DNA
2	I-DNA
receptor	I-DNA
alpha-chain	I-DNA
gene	I-DNA
and	O
the	O
beta-interferon	B-DNA
gene	I-DNA
.	O

However	O
,	O
these	O
genes	O
are	O
not	O
constitutively	O
active	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
,	O
suggesting	O
that	O
other	O
regulatory	O
mechanisms	O
must	O
play	O
a	O
role	O
in	O
determining	O
the	O
patterns	O
of	O
expression	O
.	O

We	O
have	O
investigated	O
the	O
constitutive	O
and	O
inducible	O
transcriptional	O
activity	O
mediated	O
by	O
five	O
kappa	B-DNA
B-related	I-DNA
sequence	I-DNA
elements	I-DNA
in	O
two	O
different	O
cell	O
types	O
.	O

We	O
show	O
that	O
in	O
S194	B-cell_line
plasma	I-cell_line
cells	I-cell_line
the	O
activity	O
of	O
each	O
element	O
correlates	O
well	O
with	O
the	O
relative	O
affinity	O
of	O
B-cell-derived	B-protein
NF-kappa	I-protein
B	I-protein
for	O
that	O
element	O
.	O

This	O
leads	O
to	O
significantly	O
lower	O
transcription	O
enhancement	O
by	O
sites	O
derived	O
from	O
the	O
interleukin	B-protein
2	I-protein
receptor	I-protein
or	O
T-cell	B-DNA
receptor	I-DNA
genes	I-DNA
in	O
S194	B-cell_line
cells	I-cell_line
.	O

However	O
,	O
in	O
either	O
EL-4	B-cell_line
(	I-cell_line
T	I-cell_line
)	I-cell_line
cells	I-cell_line
or	O
S194	B-cell_line
cells	I-cell_line
,	O
both	O
lower-affinity	O
sites	O
can	O
be	O
significantly	O
induced	O
by	O
the	O
tax	B-protein
gene	I-protein
product	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
,	O
showing	O
that	O
NF-kappa	B-protein
B	I-protein
activity	O
can	O
be	O
modulated	O
even	O
in	O
a	O
B-cell	B-cell_line
line	I-cell_line
that	O
constitutively	O
expresses	O
this	O
factor	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

2141-2145	NULL
,	NULL
March	NULL
1991	NULL
Immunology	NULL
Comparison	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
transcriptional	NULL
enhancement	NULL
mediated	NULL
by	NULL
«	NULL
B-related	NULL
sequences	NULL
:	NULL
Modulation	NULL
of	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
(	NULL
NF-xB/B-cell	NULL
gene	NULL
regulation	NULL
)	NULL
FABIENNE	NULL
MAUXION®*®	NULL
,	NULL
CHRISTINA	NULL
JaAMIESON*	NULL
,	NULL
MirTsUAKI	NULL
YosHIDA*	NULL
,	NULL
KEN-ICHI	NULL
AND	NULL
RaANJAN	NULL
SENn*	NULL
$	NULL
§	NULL
*Rosenstiel	NULL
Research	NULL
Center	NULL
and	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
Brandeis	NULL
University	NULL
,	NULL
Waltham	NULL
,	NULL
MA	NULL
02254-9110	NULL
;	NULL
tCancer	NULL
Institute	NULL
,	NULL
Kami-Ikebukuro	NULL
,	NULL
Toshima-ku	NULL
,	NULL
Tokyo	NULL
170	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
4-6-1	NULL
Shirokanedai	NULL
,	NULL
Minato-ku	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
Japan	NULL
Communicated	NULL
by	NULL
Alfred	NULL
Nisonoff	NULL
,	NULL
December	NULL
6	NULL
,	NULL
1990	NULL
(	NULL
received	NULL
for	NULL
review	NULL
August	NULL
20	NULL
,	NULL
1990	NULL
)	NULL
ABSTRACT	NULL
The	NULL
xB	NULL
sequence	NULL
(	NULL
GGGACTTTCC	NULL
)	NULL
binds	NULL
a	NULL
factor	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
that	NULL
is	NULL
constitutively	NULL
found	NULL
in	NULL
its	NULL
functional	NULL
,	NULL
DNA	NULL
binding	NULL
form	NULL
only	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

A	NULL
factor	NULL
with	NULL
apparently	NULL
indistinguishable	NULL
sequence	NULL
specificity	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
where	NULL
it	NULL
is	NULL
used	NULL
to	NULL
regulate	NULL
inducible	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
xB-related	NULL
sequences	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
few	NULL
inducible	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
and	NULL
the	NULL
B-interferon	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
these	NULL
genes	NULL
are	NULL
not	NULL
constitutively	NULL
active	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
regulatory	NULL
mechanisms	NULL
must	NULL
play	NULL
a	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
patterns	NULL
of	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
by	NULL
five	NULL
B-related	NULL
sequence	NULL
elements	NULL
in	NULL
two	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
show	NULL
that	NULL
in	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
element	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
relative	NULL
affinity	NULL
of	NULL
B-cell-derived	NULL
NF-xB	NULL
for	NULL
that	NULL
element	NULL
.	NULL

This	NULL
leads	NULL
to	NULL
significantly	NULL
lower	NULL
transcription	NULL
enhancement	NULL
by	NULL
sites	NULL
derived	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
or	NULL
T-cell	NULL
receptor	NULL
genes	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
either	NULL
EL-4	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
or	NULL
$	NULL
194	NULL
cells	NULL
,	NULL
both	NULL
lower-affinity	NULL
sites	NULL
can	NULL
be	NULL
significantly	NULL
induced	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
,	NULL
showing	NULL
that	NULL
NF-xB	NULL
activity	NULL
can	NULL
be	NULL
modulated	NULL
even	NULL
in	NULL
a	NULL
B-cell	NULL
line	NULL
that	NULL
constitutively	NULL
expresses	NULL
this	NULL
factor	NULL
.	NULL

B-cell-specific	NULL
activity	NULL
of	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
x	NULL
light-chain	NULL
gene	NULL
enhancer	NULL
is	NULL
directed	NULL
by	NULL
the	NULL
xB	NULL
sequence	NULL
element	NULL
(	NULL
GGGACTTTCC	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
B-lymphoid	NULL
cells	NULL
and	NULL
inducible	NULL
in	NULL
most	NULL
other	NULL
cell	NULL
types	NULL
by	NULL
various	NULL
stimuli	NULL
(	NULL
4-9	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
this	NULL
factor	NULL
may	NULL
be	NULL
further	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
or	NULL
in	NULL
B-cell	NULL
extracts	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

«	NULL
B-related	NULL
sequences	NULL
have	NULL
been	NULL
found	NULL
in	NULL
other	NULL
genes	NULL
,	NULL
where	NULL
they	NULL
are	NULL
used	NULL
to	NULL
regulate	NULL
inducible	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
such	NULL
sequence	NULL
elements	NULL
mediate	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
(	NULL
10	NULL
)	NULL
and	NULL
its	NULL
receptor	NULL
(	NULL
IL-2Ra	NULL
)	NULL
(	NULL
11-15	NULL
)	NULL
genes	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tax	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
«	NULL
B-like	NULL
sequence	NULL
from	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
IL-2Ra-B	NULL
)	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
efficiently	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
«	NULL
B-like	NULL
site	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
gene	NULL
(	NULL
TCR	NULL
$	NULL
B-B	NULL
)	NULL
serves	NULL
as	NULL
a	NULL
tax-inducible	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
is	NULL
inactive	NULL
in	NULL
NF-	NULL
«	NULL
B-containing	NULL
B	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insights	NULL
into	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
have	NULL
compared	NULL
five	NULL
«	NULL
B-like	NULL
sequences	NULL
in	NULL
terms	NULL
of	NULL
their	NULL
relative	NULL
affinity	NULL
for	NULL
B-cell-derived	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
IL-2Ra-B	NULL
and	NULL
TCR	NULL
#	NULL
B-B	NULL
sites	NULL
have	NULL
a	NULL
significantly	NULL
lower	NULL
affin-	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

2141	NULL
ity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
compared	NULL
to	NULL
the	NULL
x	NULL
enhancer	NULL
sequence	NULL
,	NULL
and	NULL
this	NULL
is	NULL
reflected	NULL
in	NULL
inefficient	NULL
transcriptional	NULL
activation	NULL
by	NULL
these	NULL
sequences	NULL
in	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
,	NULL
even	NULL
the	NULL
lower-affinity	NULL
sites	NULL
show	NULL
considerable	NULL
activity	NULL
in	NULL
EL-4	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
$	NULL
194	NULL
B	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
protein	NULL
mediating	NULL
the	NULL
induced	NULL
activity	NULL
may	NULL
be	NULL
functionally	NULL
different	NULL
from	NULL
B-cell-specific	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
demonstrating	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
can	NULL
be	NULL
further	NULL
modulated	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Constructions	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
and	NULL
a	NULL
mutated	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
m	NULL
«	NULL
B	NULL
;	NULL
GATCAGAAT-TCACTTTCCGAGA	NULL
)	NULL
,	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
plasmid	NULL
pTZ18U	NULL
to	NULL
generate	NULL
plasmids	NULL
pTZ	NULL
(	NULL
B	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
IL2R	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
BG-C	NULL
)	NULL
,	NULL
and	NULL
pTZ	NULL
(	NULL
mB	NULL
)	NULL
or	NULL
into	NULL
the	NULL
Kpn	NULL
I	NULL
site	NULL
of	NULL
plasmid	NULL
pTZ18U	NULL
to	NULL
generate	NULL
plasmid	NULL
pTZ	NULL
(	NULL
H2K	NULL
)	NULL
.	NULL

The	NULL
~40-base-pair	NULL
(	NULL
bp	NULL
)	NULL
Sma	NULL
1/Hincll	NULL
restriction	NULL
fragments	NULL
from	NULL
plasmids	NULL
pTZ	NULL
(	NULL
B	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
IL2R	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
BG-C	NULL
)	NULL
pTZ	NULL
(	NULL
mB	NULL
)	NULL
or	NULL
the	NULL
45-bp	NULL
Sma	NULL
I/EcoRI	NULL
restriction	NULL
fragment	NULL
from	NULL
plasmid	NULL
pTZ	NULL
(	NULL
H2K	NULL
)	NULL
,	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
fragment	NULL
,	NULL
were	NULL
then	NULL
sub-cloned	NULL
into	NULL
the	NULL
Sma	NULL
I	NULL
site	NULL
of	NULL
plasmid	NULL
pSPCAT	NULL
(	NULL
20	NULL
)	NULL
and	NULL
into	NULL
the	NULL
Sal	NULL
I	NULL
site	NULL
,	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
fragment	NULL
,	NULL
of	NULL
plasmid	NULL
pfosA71	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
dimer	NULL
insertions	NULL
were	NULL
selected	NULL
and	NULL
sequenced	NULL
by	NULL
the	NULL
chain-termination	NULL
method	NULL
to	NULL
determine	NULL
the	NULL
orientation	NULL
of	NULL
the	NULL
xB-related	NULL
sequences	NULL
.	NULL

Mobility-Shift	NULL
Assays	NULL
and	NULL
in	NULL
Vitro	NULL
Competitions	NULL
.	NULL

The	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
cutting	NULL
plasmid	NULL
pTZ	NULL
(	NULL
B	NULL
)	NULL
with	NULL
EcoRI	NULL
,	NULL
end-labeling	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
and	NULL
recutting	NULL
with	NULL
HindIII	NULL
.	NULL

EcoRI/HindIII	NULL
fragments	NULL
of	NULL
pTZ18U	NULL
,	NULL
pTZ	NULL
(	NULL
B	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
H2K	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
IL2R	NULL
)	NULL
,	NULL
pTZ	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
and	NULL
pTZ	NULL
(	NULL
BG-C	NULL
)	NULL
were	NULL
used	NULL
as	NULL
competitor	NULL
DNAs	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
reactions	NULL
and	NULL
electrophoretic	NULL
mobility-shift	NULL
analysis	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
1	NULL
)	NULL
with	NULL
2	NULL
ng	NULL
of	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
~20,000	NULL
cpm	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
crude	NULL
$	NULL
194	NULL
nuclear	NULL
extract	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
increasing	NULL
amounts	NULL
(	NULL
4-90	NULL
ng	NULL
)	NULL
of	NULL
competitor	NULL
DNAs	NULL
in	NULL
a	NULL
20-ul	NULL
final	NULL
vol	NULL
.	NULL

The	NULL
band	NULL
intensities	NULL
of	NULL
the	NULL
resulting	NULL
autoradiograms	NULL
were	NULL
quantified	NULL
by	NULL
two	NULL
methods	NULL
:	NULL
densitometric	NULL
scanning	NULL
of	NULL
short	NULL
time	NULL
exposures	NULL
(	NULL
with	NULL
the	NULL
Bio-Rad	NULL
video	NULL
densitometer	NULL
;	NULL
model	NULL
260	NULL
)	NULL
and	NULL
spectrophotometric	NULL
quantification	NULL
of	NULL
silver	NULL
grains	NULL
eluted	NULL
from	NULL
the	NULL
autoradiograms	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Cell	NULL
Lines	NULL
and	NULL
DNA	NULL
Transfections	NULL
.	NULL

Three	NULL
cell	NULL
lines	NULL
were	NULL
used	NULL
for	NULL
transient	NULL
transfection	NULL
experiments	NULL
:	NULL
$	NULL
194	NULL
,	NULL
a	NULL
murine	NULL
myeloma	NULL
;	NULL
Jurkat	NULL
,	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
;	NULL
EL-4	NULL
,	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
.	NULL

Culture	NULL
conditions	NULL
have	NULL
been	NULL
described	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
into	NULL
10	NULL
``	NULL
$	NULL
194	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tax	NULL
plasmid	NULL
)	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
-expressing	NULL
plas-	NULL
Abbreviations	NULL
:	NULL
IL-2Ra	NULL
,	NULL
interleukin	NULL
2	NULL
receptor	NULL
a	NULL
subunit	NULL
;	NULL
TCRB-B	NULL
,	NULL
T-cell	NULL
receptor	NULL
82	NULL
gene	NULL
intron	NULL
;	NULL
HTLV-I	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

2142	NULL
Immunology	NULL
:	NULL
Mauxion	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
A	NULL
xB	NULL
GATCCAGAGGGGACTTTCCGAGAG	NULL
H2K-B	NULL
-	NULL
CGGGCTGGGGATTCCCCATCTCGGTAC	NULL
IL2Ra-B	NULL
_	NULL
GATCCGGCAGGGGAATCTCCCTCTC	NULL
TCRB-B	NULL
-	NULL
GATCCAAGCAGGGAGATTCCAAGAG	NULL
«	NULL
BG-C	NULL
GATCAGAGGGGACTTTCCCAGA	NULL
10	NULL
7	NULL
B	NULL
4C	NULL
s	NULL
-	NULL
-o-	NULL
KB	NULL
-+-	NULL
_	NULL
H2KB	NULL
8	NULL
-S-	NULL
KBG-C	NULL
5	NULL
-	NULL
-e-	NULL
Tors	NULL
-=-	NULL
-	NULL
IL2RB	NULL
Q	NULL
-O-m	NULL
s	NULL
£	NULL
4	NULL
4	NULL
2	NULL
.C	NULL
c	NULL
2-2	NULL
1	NULL
o	NULL
I	NULL
T	NULL
U	NULL
T	NULL
U	NULL
o	NULL
'	NULL
u	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
o	NULL
10	NULL
20	NULL
Competitor	NULL
DNA	NULL
,	NULL
ng	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
present	NULL
in	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
to	NULL
«	NULL
B-related	NULL
sequence	NULL
elements	NULL
.	NULL

(	NULL
A	NULL
)	NULL
B-related	NULL
sequences	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
derived	NULL
from	NULL
«	NULL
B	NULL
,	NULL
IL-2Ra-B	NULL
,	NULL
TCRB-B	NULL
,	NULL
H2K-B	NULL
,	NULL
and	NULL
«	NULL
BG	NULL
-	NULL
C.	NULL
(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
competition	NULL
experiments	NULL
with	NULL
$	NULL
194	NULL
B-cell	NULL
extracts	NULL
to	NULL
determine	NULL
the	NULL
relative	NULL
affinity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
the	NULL
various	NULL
sequences	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
sequences	NULL
shown	NULL
in	NULL
A	NULL
were	NULL
cloned	NULL
into	NULL
plasmid	NULL
vectors	NULL
and	NULL
competitor	NULL
fragments	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
radioactive	NULL
xB	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
competitor	NULL
DNAs	NULL
followed	NULL
by	NULL
electrophoretic	NULL
mobility-shift	NULL
analysis	NULL
.	NULL

After	NULL
autoradiography	NULL
,	NULL
the	NULL
band	NULL
intensity	NULL
of	NULL
the	NULL
nucleoprotein	NULL
complex	NULL
was	NULL
quantified	NULL
and	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
y	NULL
axis	NULL
.	NULL

Concentration	NULL
of	NULL
competitor	NULL
DNA	NULL
(	NULL
in	NULL
ng	NULL
per	NULL
20	NULL
ul	NULL
of	NULL
reaction	NULL
mixture	NULL
)	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
x	NULL
axis	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Enlarged	NULL
representation	NULL
of	NULL
competition	NULL
assays	NULL
with	NULL
the	NULL
higher-affinity	NULL
sites	NULL
.	NULL

Efficiency	NULL
of	NULL
each	NULL
sequence	NULL
as	NULL
a	NULL
competitor	NULL
was	NULL
estimated	NULL
by	NULL
comparing	NULL
the	NULL
levels	NULL
needed	NULL
to	NULL
achieve	NULL
50	NULL
%	NULL
reduction	NULL
of	NULL
complex	NULL
formation	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
B	NULL
sequence	NULL
from	NULL
the	NULL
x	NULL
enhancer	NULL
:	NULL
«	NULL
B	NULL
,	NULL
100	NULL
%	NULL
;	NULL
IL-2Ra-B	NULL
,	NULL
8-10	NULL
%	NULL
;	NULL
TCRB-B	NULL
,	NULL
6-8	NULL
%	NULL
;	NULL
H2K-B	NULL
,	NULL
116	NULL
%	NULL
;	NULL
«	NULL
BG	NULL
-	NULL
C	NULL
,	NULL
181	NULL
%	NULL
.	NULL

mids	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
pCH110	NULL
that	NULL
expresses	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Extracts	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
in	NULL
a	NULL
two-phase	NULL
assay	NULL
based	NULL
on	NULL
the	NULL
diffusion	NULL
of	NULL
tritiated	NULL
acetylchloramphenicol	NULL
into	NULL
the	NULL
scintillation	NULL
fluid	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Relative	NULL
activity	NULL
of	NULL
the	NULL
plasmid	NULL
was	NULL
determined	NULL
by	NULL
dividing	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
linear	NULL
curve	NULL
obtained	NULL
for	NULL
the	NULL
plasmid	NULL
by	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
linear	NULL
curve	NULL
obtained	NULL
for	NULL
the	NULL
enhancerless	NULL
plasmid	NULL
.	NULL

Cotransfections	NULL
with	NULL
the	NULL
HTLV-I	NULL
tax-expressing	NULL
plasmid	NULL
pSRa-tax	NULL
(	NULL
25	NULL
)	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
EL-4	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
$	NULL
194	NULL
cells	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
for	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

RESULTS	NULL
The	NULL
five	NULL
related	NULL
sequences	NULL
being	NULL
considered	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Four	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
immunoglobulin	NULL
x	NULL
(	NULL
«	NULL
B	NULL
)	NULL
,	NULL
MHC-H2K®	NULL
(	NULL
H2K-B	NULL
)	NULL
,	NULL
TCRB	NULL
(	NULL
TCR	NULL
&	NULL
-B	NULL
)	NULL
,	NULL
and	NULL
IL-2Ra	NULL
(	NULL
IL-2Ra-B	NULL
)	NULL
genes	NULL
.	NULL

The	NULL
fifth	NULL
sequence	NULL
(	NULL
«	NULL
BG	NULL
-	NULL
C	NULL
)	NULL
is	NULL
a	NULL
single	NULL
base	NULL
alteration	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
that	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
(	NULL
19	NULL
)	NULL
to	NULL
bind	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
the	NULL
ubiquitous	NULL
factor	NULL
H2TFI/KBF1	NULL
.	NULL

The	NULL
relative	NULL
affinity	NULL
of	NULL
each	NULL
sequence	NULL
for	NULL
the	NULL
constitutively	NULL
present	NULL
NF-KB	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
was	NULL
assessed	NULL
by	NULL
in	NULL
vitro	NULL
competition	NULL
assays	NULL
.	NULL

For	NULL
best	NULL
comparisons	NULL
,	NULL
binding	NULL
reactions	NULL
and	NULL
electrophoretic	NULL
mobility-shift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
keeping	NULL
the	NULL
radioactive	NULL
probe	NULL
DNA	NULL
(	NULL
«	NULL
B	NULL
sequence	NULL
)	NULL
and	NULL
the	NULL
B-cell	NULL
nuclear	NULL
extract	NULL
(	NULL
derived	NULL
from	NULL
$	NULL
194	NULL
cells	NULL
)	NULL
constant	NULL
while	NULL
varying	NULL
the	NULL
nonradioactive	NULL
competitor	NULL
DNA	NULL
.	NULL

After	NULL
nondenaturing	NULL
gel	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
,	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
nucleoprotein	NULL
complex	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competitor	NULL
DNA	NULL
was	NULL
estimated	NULL
by	NULL
densitometry	NULL
and	NULL
correlated	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
range	NULL
of	NULL
competitor	NULL
concentrations	NULL
,	NULL
a	NULL
random	NULL
fragment	NULL
from	NULL
pTZ18U	NULL
(	NULL
competitor	NULL
pTZ	NULL
)	NULL
does	NULL
not	NULL
decrease	NULL
the	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
whereas	NULL
inclusion	NULL
of	NULL
any	NULL
of	NULL
the	NULL
five	NULL
«	NULL
B-related	NULL
sequences	NULL
leads	NULL
to	NULL
a	NULL
decrease	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

However	NULL
,	NULL
the	NULL
TCRB-B	NULL
and	NULL
IL-2Ra-B	NULL
sequences	NULL
clearly	NULL
competed	NULL
less	NULL
efficiently	NULL
than	NULL
either	NULL
the	NULL
«	NULL
B	NULL
,	NULL
H2K-B	NULL
,	NULL
or	NULL
«	NULL
BG	NULL
-	NULL
C	NULL
sequences	NULL
because	NULL
much	NULL
greater	NULL
amounts	NULL
of	NULL
these	NULL
DNA	NULL
fragments	NULL
were	NULL
required	NULL
to	NULL
achieve	NULL
an	NULL
equivalent	NULL
decrease	NULL
in	NULL
the	NULL
NF-kB	NULL
complex	NULL
.	NULL

Estimation	NULL
of	NULL
either	NULL
the	NULL
slopes	NULL
of	NULL
the	NULL
initial	NULL
part	NULL
of	NULL
the	NULL
curve	NULL
or	NULL
the	NULL
amounts	NULL
required	NULL
to	NULL
achieve	NULL
a	NULL
50	NULL
%	NULL
decrease	NULL
in	NULL
band	NULL
intensity	NULL
showed	NULL
that	NULL
the	NULL
IL-2Ra-B	NULL
and	NULL
TCRB-B	NULL
sequences	NULL
competed	NULL
10-	NULL
to	NULL
15-fold	NULL
less	NULL
efficiently	NULL
than	NULL
the	NULL
xB	NULL
sequence	NULL
from	NULL
the	NULL
x	NULL
enhancer	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
three	NULL
sequences	NULL
that	NULL
competed	NULL
efficiently	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
«	NULL
BG	NULL
-	NULL
>	NULL
C	NULL
sequence	NULL
was	NULL
better	NULL
than	NULL
either	NULL
xB	NULL
or	NULL
H2K-B	NULL
sequences	NULL
,	NULL
and	NULL
we	NULL
estimate	NULL
this	NULL
difference	NULL
to	NULL
be	NULL
~2-fold	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
binding	NULL
affinities	NULL
was	NULL
reproducible	NULL
in	NULL
three	NULL
independent	NULL
sets	NULL
of	NULL
competition	NULL
assays	NULL
with	NULL
two	NULL
different	NULL
preparations	NULL
of	NULL
competitor	NULL
DNA	NULL
fragments	NULL
.	NULL

To	NULL
check	NULL
the	NULL
ability	NULL
of	NULL
each	NULL
sequence	NULL
to	NULL
activate	NULL
transcrip-tion	NULL
,	NULL
two	NULL
sets	NULL
of	NULL
plasmids	NULL
carrying	NULL
each	NULL
element	NULL
were	NULL
analyzed	NULL
by	NULL
transient	NULL
transfections	NULL
into	NULL
the	NULL
murine	NULL
plasma	NULL
cell	NULL
line	NULL
$	NULL
194	NULL
.	NULL

The	NULL
five	NULL
«	NULL
B-related	NULL
sequences	NULL
were	NULL
first	NULL
cloned	NULL
as	NULL
dimers	NULL
into	NULL
the	NULL
vector	NULL
pSPCAT	NULL
(	NULL
20	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Multiple	NULL
transfections	NULL
into	NULL
$	NULL
194	NULL
cells	NULL
showed	NULL
that	NULL
the	NULL
«	NULL
BG	NULL
-	NULL
C	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
line	NULL
6	NULL
)	NULL
directed	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
CAT	NULL
enzyme	NULL
activity	NULL
followed	NULL
by	NULL
the	NULL
dB	NULL
and	NULL
H2K-B	NULL
elements	NULL
(	NULL
lines	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
H2K-B	NULL
oligonucleotide	NULL
Immunology	NULL
:	NULL
Mauxion	NULL
et	NULL
al	NULL
.	NULL

RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
IN	NULL
A	NULL
PLASMID	NULL
S194	NULL
SPCAT	NULL
1.0	NULL
(	NULL
B	NULL
)	NULL
2CAT	NULL
4	NULL
--	NULL
4	NULL
--	NULL
4.3	NULL
(	NULL
+/-	NULL
0.9	NULL
)	NULL
(	NULL
TCR2CAT	NULL
a4	NULL
--	NULL
a4	NULL
--	NULL
--	NULL
04	NULL
(	NULL
+/-0.2	NULL
)	NULL
(	NULL
H2K	NULL
)	NULL
2CAT	NULL
4	NULL
--	NULL
4	NULL
--	NULL
1.9	NULL
(	NULL
+/-0.9	NULL
)	NULL
(	NULL
IL2R	NULL
)	NULL
2CAT	NULL
4	NULL
--	NULL
4	NULL
--	NULL
0.7	NULL
(	NULL
+/-0.1	NULL
)	NULL
(	NULL
B	NULL
G-C2CAT	NULL
4	NULL
--	NULL
4	NULL
--	NULL
5.9	NULL
(	NULL
+/-0.4	NULL
)	NULL
B	NULL
PLaAsMID	NULL
fosD71	NULL
1.0	NULL
fos	NULL
(	NULL
B	NULL
)	NULL
2	NULL
--	NULL
P	NULL
--	NULL
P	NULL
9.7	NULL
(	NULL
+/-1.7	NULL
)	NULL
fos	NULL
(	NULL
TCR	NULL
)	NULL
2	NULL
--	NULL
P	NULL
--	NULL
P	NULL
1.5	NULL
(	NULL
+/-0.4	NULL
)	NULL
fos	NULL
(	NULL
H2K	NULL
)	NULL
2	NULL
4	NULL
--	NULL
4	NULL
--	NULL
-	NULL
12.3	NULL
(	NULL
+/-4.3	NULL
)	NULL
fos	NULL
(	NULL
IL2R	NULL
)	NULL
2	NULL
4	NULL
--	NULL
4	NULL
--	NULL
2.9	NULL
(	NULL
+/-0.6	NULL
)	NULL
fos	NULL
(	NULL
B	NULL
G-C	NULL
)	NULL
2	NULL
4	NULL
--	NULL
4	NULL
--	NULL
-	NULL
17.7	NULL
(	NULL
+/-4.7	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Transcription	NULL
activation	NULL
mediated	NULL
by	NULL
«	NULL
B-related	NULL
sequences	NULL
in	NULL
$	NULL
194	NULL
murine	NULL
plasma	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activation	NULL
of	NULL
an	NULL
enhancerless	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
by	NULL
«	NULL
B-related	NULL
dimers	NULL
.	NULL

«	NULL
B-related	NULL
sequences	NULL
were	NULL
cloned	NULL
into	NULL
pSPCAT	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Plasmids	NULL
p	NULL
(	NULL
B	NULL
)	NULL
2CAT	NULL
and	NULL
p	NULL
(	NULL
BG	NULL
-	NULL
>	NULL
C	NULL
)	NULL
2CAT	NULL
contain	NULL
the	NULL
«	NULL
B	NULL
and	NULL
«	NULL
BG	NULL
-	NULL
C	NULL
sequences	NULL
,	NULL
respec-tively	NULL
.	NULL

p	NULL
(	NULL
H2K	NULL
)	NULL
2CAT	NULL
,	NULL
p	NULL
(	NULL
IL2R	NULL
)	NULL
2CAT	NULL
,	NULL
and	NULL
p	NULL
(	NULL
TCR	NULL
)	NULL
2CAT	NULL
contain	NULL
the	NULL
«	NULL
B-related	NULL
sequences	NULL
derived	NULL
from	NULL
the	NULL
indicated	NULL
genes	NULL
.	NULL

Orientations	NULL
of	NULL
the	NULL
inserts	NULL
were	NULL
determined	NULL
by	NULL
dideoxynucleotide	NULL
sequencing	NULL
of	NULL
the	NULL
plasmids	NULL
and	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
.	NULL

The	NULL
arrowhead	NULL
represents	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
«	NULL
B-related	NULL
sequence	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
the	NULL
B-galactosidase-expressing	NULL
plasmid	NULL
pCH110	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

CAT	NULL
enzyme	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
48	NULL
hr	NULL
later	NULL
by	NULL
a	NULL
two-phase	NULL
assay	NULL
that	NULL
allowed	NULL
periodic	NULL
monitoring	NULL
of	NULL
the	NULL
reaction	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
plasmid	NULL
above	NULL
that	NULL
of	NULL
the	NULL
parent	NULL
vector	NULL
pSPCAT	NULL
.	NULL

Numbers	NULL
in	NULL
brackets	NULL
represent	NULL
the	NULL
standard	NULL
deviation	NULL
observed	NULL
between	NULL
six	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activation	NULL
of	NULL
a	NULL
truncated	NULL
c-fos	NULL
promoter	NULL
by	NULL
«	NULL
B-related	NULL
dimers	NULL
.	NULL

The	NULL
parent	NULL
plasmid	NULL
pfosA71	NULL
contains	NULL
nucleotides	NULL
-71	NULL
to	NULL
+109	NULL
from	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
murine	NULL
c-fos	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
.	NULL

xB-related	NULL
sequences	NULL
were	NULL
cloned	NULL
as	NULL
described	NULL
and	NULL
the	NULL
orientations	NULL
were	NULL
determined	NULL
by	NULL
dideoxynucleotide	NULL
sequencing	NULL
.	NULL

The	NULL
arrow	NULL
represents	NULL
the	NULL
same	NULL
orientation	NULL
as	NULL
described	NULL
in	NULL
A	NULL
.	NULL

Transient	NULL
cotransfections	NULL
with	NULL
pCH110	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
plasmid	NULL
above	NULL
that	NULL
of	NULL
the	NULL
parent	NULL
pfosA71	NULL
vector	NULL
.	NULL

Numbers	NULL
shown	NULL
in	NULL
brackets	NULL
are	NULL
the	NULL
standard	NULL
deviations	NULL
observed	NULL
between	NULL
six	NULL
independent	NULL
transfections	NULL
.	NULL

Normalization	NULL
to	NULL
plasmid	NULL
pfos	NULL
(	NULL
B	NULL
)	NULL
2	NULL
activity	NULL
:	NULL
pfos	NULL
(	NULL
B	NULL
)	NULL
2	NULL
,	NULL
100	NULL
%	NULL
;	NULL
pfos	NULL
(	NULL
H2K	NULL
)	NULL
2	NULL
,	NULL
127	NULL
%	NULL
;	NULL
pfos	NULL
(	NULL
IL2R	NULL
)	NULL
2	NULL
,	NULL
30	NULL
%	NULL
;	NULL
pfos	NULL
(	NULL
TCR	NULL
)	NULL
2	NULL
,	NULL
15	NULL
%	NULL
;	NULL
pfos	NULL
(	NULL
BG	NULL
-	NULL
C	NULL
)	NULL
2	NULL
,	NULL
182	NULL
%	NULL
.	NULL

directed	NULL
lower	NULL
activity	NULL
than	NULL
would	NULL
have	NULL
been	NULL
expected	NULL
based	NULL
on	NULL
its	NULL
relatively	NULL
high	NULL
affinity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
we	NULL
have	NULL
not	NULL
further	NULL
investigated	NULL
the	NULL
basis	NULL
for	NULL
this	NULL
difference	NULL
.	NULL

Interestingly	NULL
,	NULL
p	NULL
(	NULL
IL2R	NULL
)	NULL
2	NULL
CAT	NULL
and	NULL
p	NULL
(	NULL
TCR	NULL
)	NULL
2	NULL
CAT	NULL
plasmids	NULL
showed	NULL
no	NULL
detectable	NULL
activity	NULL
above	NULL
the	NULL
background	NULL
contributed	NULL
by	NULL
pSPCAT	NULL
.	NULL

Because	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
directed	NULL
only	NULL
4-	NULL
to	NULL
6-fold	NULL
activity	NULL
above	NULL
pSPCAT	NULL
,	NULL
analysis	NULL
with	NULL
this	NULL
set	NULL
of	NULL
plasmids	NULL
did	NULL
not	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
2143	NULL
allow	NULL
us	NULL
to	NULL
distinguish	NULL
whether	NULL
inactivity	NULL
of	NULL
p	NULL
(	NULL
IL-2R	NULL
)	NULL
2CAT	NULL
and	NULL
p	NULL
(	NULL
TCR	NULL
)	NULL
2CAT	NULL
was	NULL
due	NULL
to	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
threshold	NULL
affinity	NULL
for	NULL
NF-kB	NULL
to	NULL
activate	NULL
a	NULL
particular	NULL
sequence	NULL
or	NULL
because	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
plasmids	NULL
was	NULL
10-fold	NULL
lower	NULL
than	NULL
the	NULL
activity	NULL
of	NULL
p	NULL
(	NULL
B	NULL
)	NULL
2	NULL
CAT	NULL
and	NULL
therefore	NULL
could	NULL
not	NULL
be	NULL
measured	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

To	NULL
circumvent	NULL
this	NULL
problem	NULL
,	NULL
a	NULL
second	NULL
set	NULL
of	NULL
plasmids	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
same	NULL
set	NULL
of	NULL
sequences	NULL
to	NULL
activate	NULL
a	NULL
truncated	NULL
c-fos	NULL
gene	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
these	NULL
plasmids	NULL
into	NULL
$	NULL
194	NULL
cells	NULL
showed	NULL
that	NULL
,	NULL
in	NULL
this	NULL
context	NULL
,	NULL
all	NULL
plasmids	NULL
were	NULL
able	NULL
to	NULL
direct	NULL
transcriptional	NULL
activation	NULL
above	NULL
the	NULL
promoter	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

As	NULL
before	NULL
,	NULL
the	NULL
highest	NULL
activity	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
«	NULL
BG	NULL
-	NULL
>	NULL
C	NULL
sequence	NULL
(	NULL
~18-fold	NULL
above	NULL
the	NULL
background	NULL
of	NULL
the	NULL
promoter	NULL
alone	NULL
)	NULL
;	NULL
the	NULL
xB	NULL
(	NULL
~10-fold	NULL
above	NULL
)	NULL
and	NULL
H2K-B	NULL
sequences	NULL
(	NULL
~12-fold	NULL
above	NULL
)	NULL
directed	NULL
comparable	NULL
CAT	NULL
activity	NULL
[	NULL
showing	NULL
that	NULL
the	NULL
low	NULL
activity	NULL
of	NULL
plasmid	NULL
p	NULL
(	NULL
H2K	NULL
)	NULL
2	NULL
CAT	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
was	NULL
not	NULL
because	NULL
of	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
H2K-B	NULL
sequence	NULL
itself	NULL
]	NULL
and	NULL
both	NULL
the	NULL
IL-2Ra-B	NULL
and	NULL
TCR	NULL
#	NULL
3-B	NULL
elements	NULL
showed	NULL
de-tectable	NULL
,	NULL
although	NULL
low	NULL
,	NULL
activity	NULL
above	NULL
the	NULL
background	NULL
contributed	NULL
by	NULL
the	NULL
promoter	NULL
alone	NULL
(	NULL
~3-fold	NULL
and	NULL
1.5-fold	NULL
above	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
transfections	NULL
with	NULL
the	NULL
c-fos	NULL
promot-er-based	NULL
plasmids	NULL
were	NULL
normalized	NULL
to	NULL
a	NULL
cotransfected	NULL
B-galactosidase-expressing	NULL
plasmid	NULL
pCH110	NULL
(	NULL
23	NULL
)	NULL
and	NULL
the	NULL
CAT	NULL
enzyme	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
two-phase	NULL
assay	NULL
that	NULL
allowed	NULL
continuous	NULL
monitoring	NULL
of	NULL
the	NULL
reaction	NULL
so	NULL
that	NULL
small	NULL
differences	NULL
could	NULL
be	NULL
reliably	NULL
estimated	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
within	NULL
the	NULL
15-	NULL
to	NULL
20-fold	NULL
affinity	NULL
range	NULL
of	NULL
«	NULL
B-related	NULL
sequences	NULL
examined	NULL
here	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
a	NULL
site	NULL
for	NULL
NF-kB	NULL
correlates	NULL
well	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
direct	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Multimerized	NULL
IL-2Ra	NULL
sites	NULL
(	NULL
11	NULL
,	NULL
14	NULL
)	NULL
as	NULL
well	NULL
as	NULL
a	NULL
dimer	NULL
of	NULL
the	NULL
TCR	NULL
#	NULL
site	NULL
(	NULL
18	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
HTLV-I	NULL
tax-inducible	NULL
transcription	NULL
in	NULL
Jurkat	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
those	NULL
experiments	NULL
,	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
plasmids	NULL
in	NULL
B-cell	NULL
lines	NULL
was	NULL
not	NULL
examined	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
how	NULL
a	NULL
particular	NULL
sequence	NULL
responds	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
constitutive	NULL
NF-KB	NULL
compared	NULL
to	NULL
fax-induced	NULL
NF-kB	NULL
.	NULL

To	NULL
extend	NULL
the	NULL
previous	NULL
analysis	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
to	NULL
better	NULL
compare	NULL
tax-inducible	NULL
transcription	NULL
mediated	NULL
by	NULL
«	NULL
B-related	NULL
sequences	NULL
,	NULL
we	NULL
transfected	NULL
murine	NULL
EL-4	NULL
cells	NULL
with	NULL
the	NULL
pSPCAT-derived	NULL
plasmids	NULL
.	NULL

[	NULL
The	NULL
c-fos-derived	NULL
plasmids	NULL
could	NULL
not	NULL
be	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
because	NULL
the	NULL
remaining	NULL
71	NULL
bp	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
contain	NULL
a	NULL
strong	NULL
fax-inducible	NULL
element	NULL
(	NULL
C.J	NULL
.	NULL

and	NULL
R.S	NULL
.	NULL

,	NULL
unpublished	NULL
results	NULL
)	NULL
;	NULL
this	NULL
effect	NULL
is	NULL
perhaps	NULL
mediated	NULL
by	NULL
the	NULL
cAMP	NULL
responsive	NULL
element	NULL
located	NULL
between	NULL
residues	NULL
-59	NULL
and	NULL
-71	NULL
(	NULL
26	NULL
)	NULL
.	NULL
]	NULL

As	NULL
expected	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tax	NULL
,	NULL
all	NULL
plasmids	NULL
showed	NULL
equivalent	NULL
basal	NULL
level	NULL
activity	NULL
.	NULL

Cotransfection	NULL
with	NULL
the	NULL
tax-expressing	NULL
plasmid	NULL
,	NULL
pSRa-tax	NULL
,	NULL
induced	NULL
transcription	NULL
of	NULL
plasmids	NULL
containing	NULL
IL-2Ra-B	NULL
as	NULL
well	NULL
as	NULL
elements	NULL
but	NULL
not	NULL
one	NULL
containing	NULL
a	NULL
mutated	NULL
«	NULL
B	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
p	NULL
(	NULL
IL2R	NULL
)	NULL
2CAT	NULL
and	NULL
p	NULL
(	NULL
TCR	NULL
)	NULL
2CAT	NULL
,	NULL
which	NULL
were	NULL
inactive	NULL
in	NULL
NF-	NULL
«	NULL
B-containing	NULL
B	NULL
cells	NULL
,	NULL
were	NULL
quite	NULL
active	NULL
in	NULL
EL-4	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HTLV-I	NULL
tax	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
although	NULL
the	NULL
high-affinity	NULL
«	NULL
B	NULL
site	NULL
directed	NULL
the	NULL
greatest	NULL
activ-ity	NULL
,	NULL
plasmids	NULL
containing	NULL
the	NULL
lower-affinity	NULL
sites	NULL
were	NULL
at	NULL
most	NULL
2-fold	NULL
less	NULL
active	NULL
.	NULL

This	NULL
result	NULL
contrasts	NULL
with	NULL
the	NULL
roughly	NULL
4	NULL
and	NULL
6-fold	NULL
lower	NULL
activities	NULL
of	NULL
pfos	NULL
(	NULL
IL2R	NULL
)	NULL
2CAT	NULL
and	NULL
pfos	NULL
(	NULL
TCR	NULL
)	NULL
2CAT	NULL
compared	NULL
to	NULL
pfos	NULL
(	NULL
B	NULL
)	NULL
2CAT	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
rax-inducible	NULL
NF-KB	NULL
activity	NULL
in	NULL
EL-4	NULL
cells	NULL
was	NULL
less	NULL
affected	NULL
by	NULL
sequence	NULL
differences	NULL
.	NULL

To	NULL
check	NULL
whether	NULL
tax	NULL
could	NULL
also	NULL
modulate	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
pSPCAT-based	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
srax-expressing	NULL
plasmid	NULL
into	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
.	NULL

Sur-prisingly	NULL
,	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
previously	NULL
inactive	NULL
TCRB-B-	NULL
and	NULL
IL-2Ra-B-dependent	NULL
plasmids	NULL
were	NULL
induced	NULL
significantly	NULL
,	NULL
becoming	NULL
as	NULL
active	NULL
as	NULL
the	NULL
«	NULL
B-dependent	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
in	NULL
EL-4	NULL
cells	NULL
,	NULL
a	NULL
mutant	NULL
«	NULL
B	NULL
element	NULL
[	NULL
(	NULL
mB	NULL
)	NULL
2CAT	NULL
]	NULL
displayed	NULL
insignificant	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tax	NULL
,	NULL
showing	NULL
that	NULL
induction	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
«	NULL
B-related	NULL
sequences	NULL
in	NULL
the	NULL
other	NULL
plasmids	NULL
.	NULL

These	NULL
results	NULL
2144	NULL
Immunology	NULL
:	NULL
Mauxion	NULL
et	NULL
al	NULL
.	NULL

20	NULL
p	NULL
A	NULL
o	NULL
23	NULL
«	NULL
-	NULL
16	NULL
|-_	NULL
>	NULL
»	NULL
14	NULL
|-E	NULL
12	NULL
F	NULL
a	NULL
J	NULL
2	NULL
10	NULL
}	NULL
8	NULL
§	NULL
sf	NULL
2	NULL
§	NULL
}	NULL
*	NULL
9	NULL
+	NULL
}	NULL
``	NULL
af	NULL
[	NULL
_	NULL
]	NULL
0	NULL
t	NULL
i	NULL
i	NULL
iz	NULL
d	NULL
-	NULL
d	NULL
-	NULL
d	NULL
-	NULL
d	NULL
O	NULL
O	NULL
O	NULL
O	NULL
a~	NULL
a~	NULL
a	NULL
%	NULL
%	NULL
£	NULL
3	NULL
-	NULL
£	NULL
6	NULL
r-	NULL
B	NULL
g	NULL
50	NULL
f	NULL
I	NULL
S	NULL
E	NULL
4	NULL
}	NULL
I	NULL
£	NULL
&	NULL
wl	NULL
I	NULL
3	NULL
€	NULL
20	NULL
|-3	NULL
0	NULL
9	NULL
40	NULL
}	NULL
®	NULL
0	NULL
(	NULL
B	NULL
)	NULL
2CAT	NULL
(	NULL
mB	NULL
)	NULL
2CAT	NULL
:	NULL
|	NULL
'	NULL
(	NULL
IL2R	NULL
)	NULL
2CAT	NULL
(	NULL
TCR	NULL
)	NULL
2CAT	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Increased	NULL
activity	NULL
of	NULL
low-affinity	NULL
«	NULL
B-related	NULL
sequences	NULL
in	NULL
murine	NULL
EL-4	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
$	NULL
194	NULL
B	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Inducible	NULL
activity	NULL
of	NULL
pSPCAT-derived	NULL
plasmids	NULL
in	NULL
EL-4	NULL
cells	NULL
.	NULL

pSPCAT-derived	NULL
plasmids	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
containing	NULL
dimers	NULL
of	NULL
the	NULL
TCRB-B	NULL
sequence	NULL
,	NULL
the	NULL
IL-2Ra-B	NULL
sequence	NULL
,	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
,	NULL
or	NULL
a	NULL
mutated	NULL
xB	NULL
sequence	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
EL-4	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
carrier	NULL
DNA	NULL
(	NULL
pTZ18U	NULL
)	NULL
or	NULL
a	NULL
plasmid	NULL
expressing	NULL
HTLV-I	NULL
tax	NULL
(	NULL
pSRa-tax	NULL
)	NULL
followed	NULL
by	NULL
CAT	NULL
enzyme	NULL
analysis	NULL
40-48	NULL
hr	NULL
later	NULL
.	NULL

Fold	NULL
induction	NULL
on	NULL
the	NULL
y	NULL
axis	NULL
refers	NULL
to	NULL
the	NULL
ratio	NULL
(	NULL
activity	NULL
of	NULL
xB-containing	NULL
plasmid	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tax	NULL
)	NULL
/	NULL
(	NULL
activity	NULL
of	NULL
«	NULL
B-containing	NULL
plasmid	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pTZ	NULL
)	NULL
.	NULL

Results	NULL
presented	NULL
are	NULL
an	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inducible	NULL
activity	NULL
of	NULL
pSPCAT-derived	NULL
plasmids	NULL
in	NULL
murine	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
.	NULL

pSPCAT-derived	NULL
plasmids	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
$	NULL
194	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
carrier	NULL
DNA	NULL
(	NULL
pTZ18U	NULL
)	NULL
or	NULL
pSRa-tax	NULL
expressing	NULL
the	NULL
HTLV-I	NULL
rax	NULL
gene	NULL
product	NULL
.	NULL

The	NULL
y	NULL
axis	NULL
shows	NULL
the	NULL
tax-induced	NULL
activity	NULL
of	NULL
the	NULL
plasmids	NULL
represented	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
chloramphenicol	NULL
converted	NULL
to	NULL
its	NULL
acetylated	NULL
form	NULL
.	NULL

Results	NULL
shown	NULL
were	NULL
obtained	NULL
from	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

showed	NULL
that	NULL
the	NULL
tax	NULL
gene	NULL
product	NULL
can	NULL
function	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
to	NULL
modulate	NULL
the	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
so	NULL
that	NULL
even	NULL
low-affinity	NULL
«	NULL
B-related	NULL
sequences	NULL
were	NULL
able	NULL
to	NULL
confer	NULL
significant	NULL
transcriptional	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
close	NULL
correlation	NULL
ob	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
served	NULL
between	NULL
the	NULL
relative	NULL
binding	NULL
affinity	NULL
of	NULL
a	NULL
sequence	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
appears	NULL
to	NULL
break	NULL
down	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HTLV-I	NULL
tax	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
affinity	NULL
of	NULL
B-cell-derived	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
kB-related	NULL
sequences	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
sequences	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
$	NULL
194	NULL
murine	NULL
plasma	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
IL-2Ra-B	NULL
and	NULL
TCRB-B	NULL
motifs	NULL
are	NULL
bound	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
10-	NULL
to	NULL
15-fold	NULL
more	NULL
weakly	NULL
than	NULL
the	NULL
«	NULL
B	NULL
site	NULL
and	NULL
they	NULL
activate	NULL
transcription	NULL
4-	NULL
to	NULL
7-fold	NULL
less	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
this	NULL
pattern	NULL
of	NULL
affinity	NULL
and	NULL
expression	NULL
is	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
levels	NULL
are	NULL
limiting	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
higher-affinity	NULL
sites	NULL
are	NULL
able	NULL
to	NULL
more	NULL
efficiently	NULL
utilize	NULL
a	NULL
restricted	NULL
amount	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
a	NULL
dimer	NULL
of	NULL
the	NULL
IL-2Ra-B	NULL
site	NULL
is	NULL
a	NULL
poor	NULL
activator	NULL
of	NULL
transcription	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
an	NULL
earlier	NULL
report	NULL
that	NULL
showed	NULL
that	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
containing	NULL
the	NULL
IL-2Ra-B	NULL
site	NULL
was	NULL
unable	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
explanation	NULL
proposed	NULL
by	NULL
Cross	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
)	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
this	NULL
observation	NULL
can	NULL
be	NULL
readily	NULL
explained	NULL
by	NULL
the	NULL
significantly	NULL
lower	NULL
affinity	NULL
of	NULL
the	NULL
sequence	NULL
for	NULL
B-cell-derived	NULL
NF-kB	NULL
.	NULL

Furthermore	NULL
,	NULL
both	NULL
sequences	NULL
(	NULL
IL-2Ra-B	NULL
and	NULL
TCRRB-B	NULL
)	NULL
that	NULL
have	NULL
a	NULL
relatively	NULL
low	NULL
affinity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
presumably	NULL
therefore	NULL
do	NULL
not	NULL
confer	NULL
transcriptional	NULL
activity	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
,	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
Jurkat	NULL
(	NULL
refs	NULL
.	NULL

11	NULL
,	NULL
14	NULL
,	NULL
and	NULL
18	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
EL-4	NULL
T	NULL
cells	NULL
and	NULL
$	NULL
194	NULL
cells	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
HTLV-I	NULL
tax	NULL
.	NULL

We	NULL
note	NULL
an	NULL
interesting	NULL
similarity	NULL
between	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
complete	NULL
IL-2Ra	NULL
promoter	NULL
and	NULL
a	NULL
dimer	NULL
of	NULL
the	NULL
IL-2Ra-B	NULL
site	NULL
.	NULL

The	NULL
IL-2Ra	NULL
chain	NULL
is	NULL
present	NULL
in	NULL
low	NULL
amounts	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
resting	NULL
lymphocytes	NULL
.	NULL

Activation	NULL
of	NULL
either	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
or	NULL
B	NULL
cells	NULL
(	NULL
29-31	NULL
)	NULL
leads	NULL
to	NULL
much	NULL
higher	NULL
levels	NULL
of	NULL
surface	NULL
expression	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
induction	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
initiation	NULL
and	NULL
it	NULL
is	NULL
quite	NULL
likely	NULL
that	NULL
the	NULL
same	NULL
is	NULL
true	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
is	NULL
active	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
dimer	NULL
of	NULL
the	NULL
IL-2Ra-B	NULL
site	NULL
mimics	NULL
this	NULL
pattern	NULL
closely	NULL
;	NULL
it	NULL
is	NULL
weakly	NULL
active	NULL
(	NULL
if	NULL
at	NULL
all	NULL
)	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
constitutively	NULL
;	NULL
however	NULL
,	NULL
upon	NULL
cellular	NULL
activation	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
by	NULL
tax	NULL
)	NULL
,	NULL
transcriptional	NULL
activity	NULL
is	NULL
strongly	NULL
induced	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
where	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
,	NULL
it	NULL
is	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
complexed	NULL
with	NULL
an	NULL
inhibitor	NULL
protein	NULL
I-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
prevents	NULL
its	NULL
nuclear	NULL
localization	NULL
and	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Upon	NULL
cellular	NULL
activation	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-I-	NULL
«	NULL
B	NULL
complex	NULL
is	NULL
disrupted	NULL
,	NULL
allowing	NULL
transport	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
protein	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
subsequent	NULL
transcriptional	NULL
activation	NULL
(	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
experiments	NULL
have	NULL
indicated	NULL
that	NULL
even	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
a	NULL
certain	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
present	NULL
as	NULL
the	NULL
inactive	NULL
cytoplasmic	NULL
complex	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Lenardo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
showed	NULL
that	NULL
virus	NULL
infection	NULL
of	NULL
human	NULL
Namaiwa	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
led	NULL
to	NULL
higher	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
than	NULL
that	NULL
found	NULL
constitutively	NULL
,	NULL
and	NULL
Visvanathan	NULL
and	NULL
Goodbourn	NULL
(	NULL
7	NULL
)	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
factor	NULL
by	NULL
treating	NULL
whole	NULL
cell	NULL
extracts	NULL
derived	NULL
from	NULL
Daudi	NULL
cells	NULL
with	NULL
mild	NULL
denaturants	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
splenic	NULL
B	NULL
cells	NULL
via	NULL
the	NULL
surface	NULL
antigen	NULL
receptor	NULL
also	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
37	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
perhaps	NULL
even	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
mediate	NULL
inducible	NULL
gene	NULL
expression	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
the	NULL
first	NULL
direct	NULL
demonstration	NULL
that	NULL
,	NULL
in	NULL
spite	NULL
of	NULL
the	NULL
constitutive	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
transcription	NULL
dependent	NULL
on	NULL
«	NULL
B-like	NULL
sequence	NULL
elements	NULL
can	NULL
be	NULL
further	NULL
modulated	NULL
in	NULL
such	NULL
cells	NULL
and	NULL
that	NULL
HTLV-I	NULL
tax	NULL
is	NULL
one	NULL
of	NULL
the	NULL
agents	NULL
capable	NULL
of	NULL
doing	NULL
so	NULL
.	NULL

The	NULL
simplest	NULL
interpretation	NULL
of	NULL
our	NULL
observations	NULL
is	NULL
that	NULL
the	NULL
tax	NULL
gene	NULL
product	NULL
activates	NULL
the	NULL
sequestered	NULL
NF-	NULL
«	NULL
B	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
larger	NULL
pool	NULL
of	NULL
available	NULL
transcription	NULL
factor	NULL
.	NULL

Once	NULL
the	NULL
levels	NULL
of	NULL
NF-KB	NULL
are	NULL
no	NULL
longer	NULL
limiting	NULL
within	NULL
Immunology	NULL
:	NULL
Mauxion	NULL
et	NULL
al	NULL
.	NULL

the	NULL
nucleus	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
affinity	NULL
differences	NULL
between	NULL
«	NULL
B-related	NULL
sequences	NULL
is	NULL
decreased	NULL
.	NULL

Alternatively	NULL
,	NULL
tax	NULL
may	NULL
induce	NULL
a	NULL
transcription	NULL
factor	NULL
(	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
)	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
effects	NULL
we	NULL
have	NULL
observed	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
consistent	NULL
with	NULL
recent	NULL
evidence	NULL
suggesting	NULL
that	NULL
xB	NULL
homolo-gous	NULL
sequence	NULL
elements	NULL
may	NULL
bind	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
DNA	NULL
binding	NULL
proteins	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
tax-encoded	NULL
protein	NULL
(	NULL
and	NULL
perhaps	NULL
other	NULL
signals	NULL
)	NULL
,	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
can	NULL
cause	NULL
a	NULL
posttranslational	NULL
modification	NULL
of	NULL
the	NULL
preexisting	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B	NULL
cells	NULL
to	NULL
generate	NULL
a	NULL
protein	NULL
functionally	NULL
different	NULL
from	NULL
the	NULL
constitutive	NULL
factor	NULL
.	NULL

Our	NULL
data	NULL
,	NULL
at	NULL
present	NULL
,	NULL
do	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
distinguish	NULL
between	NULL
these	NULL
models	NULL
but	NULL
serve	NULL
to	NULL
define	NULL
a	NULL
hitherto	NULL
unknown	NULL
facet	NULL
of	NULL
transcription	NULL
regulation	NULL
by	NULL
NF-	NULL
«	NULL
B-like	NULL
factors	NULL
as	NULL
well	NULL
as	NULL
HTLV-I	NULL
tax	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
Michael	NULL
Gilman	NULL
for	NULL
the	NULL
pfosA71	NULL
plasmid	NULL
and	NULL
Yvette	NULL
Bonilla	NULL
and	NULL
Edwina	NULL
Hertach	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manu-script	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
GM	NULL
38925-02	NULL
)	NULL
and	NULL
a	NULL
Basil	NULL
O'Connor	NULL
Starter	NULL
Scholar	NULL
Award	NULL
from	NULL
the	NULL
March	NULL
of	NULL
Dimes	NULL
Foundation	NULL
to	NULL
R.S	NULL
.	NULL

1	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

2	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
1573-1577	NULL
.	NULL

3	NULL
.	NULL

Atchison	NULL
,	NULL
M.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
121-128	NULL
.	NULL

4	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

5	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

6	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
287-294	NULL
.	NULL

7	NULL
.	NULL

Visvanathan	NULL
,	NULL
K.	NULL
V.	NULL
&	NULL
Goodbourn	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1129-1138	NULL
.	NULL

8	NULL
.	NULL

Edbrooke	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Burt	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Cheshire	NULL
,	NULL
J.	NULL
K.	NULL
&	NULL
Woo	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1908-1916	NULL
.	NULL

9	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
339	NULL
,	NULL
70-72	NULL
.	NULL

10	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Sickevitz	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
.	NULL

11	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

12	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Poteat	NULL
,	NULL
H.	NULL
,	NULL
Tan	NULL
,	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
,	NULL
Haseltine	NULL
,	NULL
W.	NULL
&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
89-92	NULL
.	NULL

13	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1652-1655	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
2145	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
827-836	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Lanyard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
466-469	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
;	NULL
Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
Tsura	NULL
,	NULL
S.	NULL
&	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
2883-2888	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Wolf	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
&	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
47-56	NULL
.	NULL

Jamieson	NULL
,	NULL
C.	NULL
,	NULL
Mauxion	NULL
,	NULL
F.	NULL
&	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
1737-1743	NULL
.	NULL

Mauxion	NULL
,	NULL
F.	NULL
&	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
3548-3552	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
Hellman	NULL
,	NULL
L.	NULL
&	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
3526-3531	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
Wilson	NULL
,	NULL
R.	NULL
N.	NULL
&	NULL
Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
4305-4316	NULL
.	NULL

Suissa	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

133	NULL
,	NULL
511-514	NULL
.	NULL

Herbomel	NULL
,	NULL
P.	NULL
,	NULL
Bourachot	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
39	NULL
,	NULL
653-662	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Morency	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Russian	NULL
,	NULL
K.	NULL
O	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Biotechniques	NULL
5	NULL
,	NULL
444-447	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Malefijt	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Heike	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Shlomai	NULL
,	NULL
J.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
6547-6566.	NULL
.	NULL

Berkowitz	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Riabowol	NULL
,	NULL
K.	NULL
T.	NULL
&	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
4272-4281	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
1169-1176.	NULL
.	NULL

Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
727-732	NULL
.	NULL

Zubler	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Erand	NULL
,	NULL
F.	NULL
,	NULL
Hashimoto	NULL
,	NULL
N.	NULL
,	NULL
Devos	NULL
,	NULL
R.	NULL
&	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
1170-1183	NULL
,	NULL
Mingari	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Gerosa	NULL
,	NULL
F.	NULL
,	NULL
Carra	NULL
,	NULL
G.	NULL
,	NULL
Accolla	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Moretta	NULL
,	NULL
A.	NULL
,	NULL
Zubler	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Moretta	NULL
,	NULL
L.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
312	NULL
,	NULL
641-643	NULL
.	NULL

Ortega	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Robb	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Shevach	NULL
,	NULL
E.	NULL
M.	NULL
&	NULL
Malek	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

133	NULL
,	NULL
1970-1975	NULL
.	NULL

Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-545	NULL
.	NULL

Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Duyao	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Buckler	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
4727-4731	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Chiles	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
&	NULL
Rothstein	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

